IP Library Granted Patent US 10,138,461
Granted Patent B2
US 10,138,461 · App. 15/712,408 · Granted Nov 27, 2018

Animal protein-free media for cultivation of cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,138,461
App. No.
15/712,408
Granted
Nov 27, 2018
Kind
B2
Abstract

The present invention relates to animal protein-free cell culture media comprising polyamines and a plant- and/or yeast-derived hydrolysate. The invention also relates to animal protein-free culturing processes, wherein cells can be cultivated, propagated and passaged without adding supplementary animal proteins in the culture medium. These processes are useful in cultivating cells, such as recombinant cells or cells infected with a virus, and for producing biological products by cell culture processes.

Claims (21)

1. An animal protein-free cell culture medium, comprising at least one polyamine and at least one protein hydrolysate derived from the group consisting of plants and yeast, wherein the polyamine is present in the culture medium in a concentration ranging from about 0.5 to about 30 mg/L.

2. The animal protein-free cell culture medium according to claim 1 , wherein the polyamine is selected from the group consisting of cadaverine, putrescine, spermidine, spermine, agmatine, ornithine, and a combination thereof.

3. The animal protein-free cell culture medium according to claim 1 , wherein the polyamine is putrescine in a concentration ranging from about 0.5 to about 10 mg/L, and the protein hydrolysate is soy hydrolysate in a concentration ranging from about 0.05% (w/v) to about 5% (w/v).

4. The animal protein-free cell culture medium according to claim 1 , wherein the polyamine originates from a source other than a protein hydrolysate.

5. The animal protein-free cell culture medium according to claim 1 , wherein the polyamine is present in the culture medium in a concentration ranging from about 0.5 to about 10 mg/L.

6. The animal protein-free cell culture medium according to claim 1 , wherein the polyamine is present in the culture medium in a concentration ranging from about 2 to about 8 mg/L.

7. The animal protein-free cell culture medium according to claim 1 , wherein the protein hydrolysate is present in the culture medium in a total concentration ranging from about 0.05% (w/v) to about 5% (w/v) for all protein hydrolysates.

8. The animal protein-free cell culture medium according to claim 1 , wherein the protein hydrolysate is derived from a plant selected from the group consisting cereals and soy.

9. A method for cultivating cells, comprising the steps of:

(a) providing an animal protein-free cell culture medium according to claim 1 , and

(b) propagating the cells in the medium to form a cell culture.

10. The method according to claim 9 , wherein the cells are selected from the group consisting of mammalian cells, insect cells, avian cells, bacterial cells, and yeast cells.

11. The method according to claim 9 , wherein the cells are cultivated by a method selected from the group consisting of batch-cultivation, feed-batch-cultivation, perfusion cultivation, and chemostat-cultivation.

12. A method for expressing a target protein, comprising the steps of:

a) providing a culture of cells that have been grown in an animal protein-free cell culture medium according to claim 1 ;

b) introducing a nucleic acid sequence comprising a sequence coding for the target protein into the cells;

c) selecting the cells carrying the nucleic acid sequence; and

d) selectively inducing the expression of the target protein in the cells.

13. The method according to claim 12 , wherein the cells are selected from the group consisting of mammalian cells, insect cells, avian cells, bacterial cells, and yeast cells.

14. The method according to claim 1 wherein the cell/target protein combination is selected from the group consisting of CHO cells/coagulation factor VIII, BHK cells/erythropoietin, Epstein Barr virus transformed, immortalized human B cells/human antibodies.

15. The method according to claim 12 , wherein the cells are cultivated by a method selected from the group consisting of batch-cultivation, feed-batch-cultivation, perfusion cultivation, and chemostat-cultivation.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0005 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2017
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 044280/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2017
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 044597/0216 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2017
From: GRILLBERGER, LEOPOLD; REITER, MANFRED; MUNDT, WOLFGANG; DORNER, FRIEDRICH
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 043933/0480 →
Cited By (2)
US 12,668,774 US 12,686,847